US Medicare Wastage ‘Refund’: Wasted Effort?
Executive Summary
The upcoming implementation of a new ‘refund’ program for unused drugs included in single-use vials is a remarkable story of a policy idea moving from academic research into the real world. But the actual impact sure has shrunk along the way.
You may also be interested in...
Medicare Rebates On Drug ‘Wastage’: New Products Get Limited Time Reprieve
Regulation from CMS may drive manufacturers to repackage Medicare Part B drugs sold in single-use containers to avoid waste that would be subject to new rebate.
Rebate Proposals Targeting Single-Use Vials May Be Barking Up The Wrong Tree
Policymakers should instead focus on increasing efficiencies in drug development, distribution and reimbursement, National Academies report says, while also seeking broad policies like HHS direct negotiation for drug prices in Medicare.
Cancer Drug "Oversized" Single-Dose Vials Waste Money, Need Rethinking – Article
Amgen, Takeda and Merck push back against article’s conclusions on the waste generated by current vials for infused drugs.